BLT Secures Orders from Multiple Countries, AniView Series In Vivo Imaging Systems Demonstrate International Competitiveness

Recently, Guangzhou Biolight Biotechnology Co., Ltd. (hereinafter referred to as “BLT”) announced that its core product, the AniView series of live imaging systems, has secured a series of significant orders in overseas markets. Customers span major research institutions and enterprises across multiple countries, including South Korea, Japan, Uzbekistan, Turkey and Spain. The recent concentrated tender winning on multiple models across several countries not only validates the exceptional performance and reliable quality of BLT's products, which have gained widespread recognition in the international market, but also marks a new breakthrough in the company's journey to expand its overseas presence.

Overseas markets deliver frequent good news, with high-end scientific research clients providing endorsements.

1. Korea Advanced Institute of Science and Technology (KAIST) — Procurement of AniView100 Pro

2. Korea Ewha Womans University College of Medicine — Procurement of AniView600

3. Miyazaki University, Japan — Procurement of AniView600 Kirin

4. Uzbekistan Academy of Sciences — Procurement of AniView600

5. Turkey Kobay Company—— Procurement of AniView SE

6. Teatinos-Universidad—— Procurement of Gelview 6000Pro II

These orders cover diverse requirements from fundamental research to high-end applications, fully demonstrating the AniView and Gelview series' extensive range of models, comprehensive configurations, and outstanding performance—capable of meeting the requirements of scientific users across different regions worldwide.

Deep roots in the local market build strength, Leading position underpins global expansion.

As a domestic industry leader, BLT has established a dominant position in the Chinese market with its AniView series of live imaging systems, through their exceptional performance and stability. This leadership stems from the company's sustained investment in core technologies and relentless pursuit of product excellence. Deep roots in the local market and successful practice have equipped BLT with robust R&D iteration capabilities, mature solutions, and scaled-up supply assurance. These form the core confidence and solid foundation for its expansion into international markets.

Expanding our global footprint with strength, Our international strategy is beginning to bear fruit.

Recent tender winning in multiple countries represents a key achievement in BLT's international strategic expansion. Leveraging superior product technology, competitive pricing, and a comprehensive after-sales service system, the company has successfully broken through international market barriers and earned the trust of overseas clients. From East Asia's technological powerhouses to Central Asia's research hubs, and now into the Eurasian market of Turkey, BLT's footprint is rapidly expanding, signifying its growing global brand influence.

In the future, BLT will continue to uphold the philosophy of “innovation-driven, quality-oriented.” While consolidating and expanding its competitive edge in the domestic market, the company will more actively advance its globalization strategy. It will introduce more high-performance, cost-effective scientific instruments to the world, contributing Chinese wisdom and strength to global life science research.